{
    "info": {
        "nct_id": "NCT05102370",
        "official_title": "A Pilot Study of Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2",
        "inclusion_criteria": "* Age ≥18 years at the time of signing the informed consent form.\n* Willing and able to adhere to the study visit schedule and other protocol requirements.\n* Unexplained cytopenia for at least 6 months. Cytopenia is defined as the presence of ≥1 blood count indexes below the following thresholds:\n* Hgb <10 g/dL\n* ANC <1.8 × 10^9/L\n* Platelets <100 × 10^9/L\n* Results of bone marrow biopsy within 1 month of study entry (screening bone marrow biopsy) must not indicate hematologic disease.\n* IDH2 gene mutation (R140 or R172), performed locally, at a frequency >2%.\n* ECOG performance status of 0-2.\n* Adequate organ function, defined as:\n\n  * Serum aspartate aminotransferase/serum glutamic oxaloacetic transaminase (AST/SGOT) and alanine aminotransferase (ALT/SGPT) ≤3x upper limit of normal (ULN), unless the subject has Gilbert's syndrome.\n  * Serum total bilirubin <1.5x ULN. Higher levels are acceptable if these can be attributed to ineffective erythropoiesis. In these cases, approval from the study Principal Investigator is required.\n  * Creatinine clearance greater than 50 mL/min based on the Cockroft-Gault glomerular filtration rate estimation.\n* Patients being enrolled on study on the basis of anemia, will only be eligible if folate, B12, serum iron, serum ferritin, total iron binding capacity, haptoglobin and peripheral smear within normal limits\n* Women of childbearing potential may participate provided they have a negative serum pregnancy test at screening and a negative serum or urine pregnancy test within 72 h of starting treatment.\n* Women of childbearing potential (WOCBP) and males with partners who are WOCBP must agree to abstain from sexual intercourse or to use 1 highly effective form of contraception during the study and for at least 4 months following the last dose of enasidenib. Males with partners who are WOCBP must agree to use a barrier method.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Active malignancy defined as >1-cm disease on most recent CT scan in the past 6 months or recent history of cancer (i.e. within the past 5 years) with >50% chance of cancer recurrence in the next 5 years.\n* Current or prior history of hematologic malignancy.\n* Therapy (including maintenance therapy) for solid-tumor malignancy within the last 6 months.\n* Known dysphagia, short-gut syndrome, gastroparesis, or other conditions that limit the ingestion or gastrointestinal absorption of drugs administered orally.\n* Active uncontrolled systemic fungal, bacterial, or viral infection (defined as ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment).\n* Positive direct Coombs test\n* Evidence of hypersplenism on physical exam\n* Pregnant or lactating (women).",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0-2.",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets <100 × 10^9/L",
            "criterions": [
                {
                    "exact_snippets": "Platelets <100 × 10^9/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 100,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Results of bone marrow biopsy within 1 month of study entry (screening bone marrow biopsy) must not indicate hematologic disease.",
            "criterions": [
                {
                    "exact_snippets": "Results of bone marrow biopsy within 1 month of study entry (screening bone marrow biopsy) must not indicate hematologic disease.",
                    "criterion": "bone marrow biopsy results",
                    "requirements": [
                        {
                            "requirement_type": "presence of hematologic disease",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ANC <1.8 × 10^9/L",
            "criterions": [
                {
                    "exact_snippets": "ANC <1.8 × 10^9/L",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.8,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential (WOCBP) and males with partners who are WOCBP must agree to abstain from sexual intercourse or to use 1 highly effective form of contraception during the study and for at least 4 months following the last dose of enasidenib. Males with partners who are WOCBP must agree to use a barrier method.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential (WOCBP) and males with partners who are WOCBP must agree to abstain from sexual intercourse or to use 1 highly effective form of contraception during the study and for at least 4 months following the last dose of enasidenib.",
                    "criterion": "contraception agreement (WOCBP and males with WOCBP partners)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to contraception or abstinence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Males with partners who are WOCBP must agree to use a barrier method.",
                    "criterion": "barrier contraception agreement (males with WOCBP partners)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use barrier method",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥18 years at the time of signing the informed consent form.",
            "criterions": [
                {
                    "exact_snippets": "Age ≥18 years at the time of signing the informed consent form.",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine clearance greater than 50 mL/min based on the Cockroft-Gault glomerular filtration rate estimation.",
            "criterions": [
                {
                    "exact_snippets": "Creatinine clearance greater than 50 mL/min ... based on the Cockroft-Gault glomerular filtration rate estimation",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 50,
                                "unit": "mL/min"
                            }
                        },
                        {
                            "requirement_type": "estimation_method",
                            "expected_value": "Cockroft-Gault glomerular filtration rate estimation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function, defined as:",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hgb <10 g/dL",
            "criterions": [
                {
                    "exact_snippets": "Hgb <10 g/dL",
                    "criterion": "hemoglobin (Hgb) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing and able to adhere to the study visit schedule and other protocol requirements.",
            "criterions": [
                {
                    "exact_snippets": "Willing ... adhere to the study visit schedule",
                    "criterion": "adherence to study visit schedule",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to adhere to ... other protocol requirements",
                    "criterion": "adherence to other protocol requirements",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* IDH2 gene mutation (R140 or R172), performed locally, at a frequency >2%.",
            "criterions": [
                {
                    "exact_snippets": "IDH2 gene mutation (R140 or R172)",
                    "criterion": "IDH2 gene mutation",
                    "requirements": [
                        {
                            "requirement_type": "mutation_presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "mutation_type",
                            "expected_value": [
                                "R140",
                                "R172"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "performed locally",
                    "criterion": "IDH2 gene mutation testing location",
                    "requirements": [
                        {
                            "requirement_type": "testing_location",
                            "expected_value": "local"
                        }
                    ]
                },
                {
                    "exact_snippets": "at a frequency >2%",
                    "criterion": "IDH2 gene mutation frequency",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Unexplained cytopenia for at least 6 months. Cytopenia is defined as the presence of ≥1 blood count indexes below the following thresholds:",
            "criterions": [
                {
                    "exact_snippets": "Unexplained cytopenia for at least 6 months",
                    "criterion": "cytopenia",
                    "requirements": [
                        {
                            "requirement_type": "cause",
                            "expected_value": "unexplained"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Cytopenia is defined as the presence of ≥1 blood count indexes below the following thresholds",
                    "criterion": "blood count indexes",
                    "requirements": [
                        {
                            "requirement_type": "quantity_below_threshold",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "index"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum total bilirubin <1.5x ULN. Higher levels are acceptable if these can be attributed to ineffective erythropoiesis. In these cases, approval from the study Principal Investigator is required.",
            "criterions": [
                {
                    "exact_snippets": "Serum total bilirubin <1.5x ULN",
                    "criterion": "serum total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Higher levels are acceptable if these can be attributed to ineffective erythropoiesis",
                    "criterion": "serum total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": ">=1.5x ULN"
                        },
                        {
                            "requirement_type": "cause",
                            "expected_value": "ineffective erythropoiesis"
                        }
                    ]
                },
                {
                    "exact_snippets": "approval from the study Principal Investigator is required",
                    "criterion": "serum total bilirubin (with higher levels due to ineffective erythropoiesis)",
                    "requirements": [
                        {
                            "requirement_type": "approval",
                            "expected_value": "study Principal Investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential may participate provided they have a negative serum pregnancy test at screening and a negative serum or urine pregnancy test within 72 h of starting treatment.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive status",
                            "expected_value": "of childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "negative serum pregnancy test at screening",
                    "criterion": "serum pregnancy test at screening",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "negative serum or urine pregnancy test within 72 h of starting treatment",
                    "criterion": "pregnancy test within 72 h of starting treatment",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "serum",
                                "urine"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "within 72 h of starting treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum aspartate aminotransferase/serum glutamic oxaloacetic transaminase (AST/SGOT) and alanine aminotransferase (ALT/SGPT) ≤3x upper limit of normal (ULN), unless the subject has Gilbert's syndrome.",
            "criterions": [
                {
                    "exact_snippets": "Serum aspartate aminotransferase/serum glutamic oxaloacetic transaminase (AST/SGOT) ... ≤3x upper limit of normal (ULN)",
                    "criterion": "serum aspartate aminotransferase (AST/SGOT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT/SGPT) ≤3x upper limit of normal (ULN)",
                    "criterion": "alanine aminotransferase (ALT/SGPT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unless the subject has Gilbert's syndrome",
                    "criterion": "Gilbert's syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients being enrolled on study on the basis of anemia, will only be eligible if folate, B12, serum iron, serum ferritin, total iron binding capacity, haptoglobin and peripheral smear within normal limits",
            "criterions": [
                {
                    "exact_snippets": "folate ... within normal limits",
                    "criterion": "folate level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "B12 ... within normal limits",
                    "criterion": "B12 level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "serum iron ... within normal limits",
                    "criterion": "serum iron level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "serum ferritin ... within normal limits",
                    "criterion": "serum ferritin level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "total iron binding capacity ... within normal limits",
                    "criterion": "total iron binding capacity",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "haptoglobin ... within normal limits",
                    "criterion": "haptoglobin level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                },
                {
                    "exact_snippets": "peripheral smear within normal limits",
                    "criterion": "peripheral smear",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "within normal limits"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Pregnant or lactating (women).",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating (women)",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Therapy (including maintenance therapy) for solid-tumor malignancy within the last 6 months.",
            "criterions": [
                {
                    "exact_snippets": "Therapy (including maintenance therapy) for solid-tumor malignancy within the last 6 months.",
                    "criterion": "therapy for solid-tumor malignancy",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current or prior history of hematologic malignancy.",
            "criterions": [
                {
                    "exact_snippets": "Current or prior history of hematologic malignancy",
                    "criterion": "hematologic malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Positive direct Coombs test",
            "criterions": [
                {
                    "exact_snippets": "Positive direct Coombs test",
                    "criterion": "direct Coombs test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of hypersplenism on physical exam",
            "criterions": [
                {
                    "exact_snippets": "Evidence of hypersplenism on physical exam",
                    "criterion": "hypersplenism",
                    "requirements": [
                        {
                            "requirement_type": "evidence_on_physical_exam",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known dysphagia, short-gut syndrome, gastroparesis, or other conditions that limit the ingestion or gastrointestinal absorption of drugs administered orally.",
            "criterions": [
                {
                    "exact_snippets": "Known dysphagia",
                    "criterion": "dysphagia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "short-gut syndrome",
                    "criterion": "short-gut syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "gastroparesis",
                    "criterion": "gastroparesis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other conditions that limit the ingestion or gastrointestinal absorption of drugs administered orally",
                    "criterion": "conditions limiting oral drug ingestion or gastrointestinal absorption",
                    "requirements": [
                        {
                            "requirement_type": "effect",
                            "expected_value": "limits ingestion or gastrointestinal absorption of orally administered drugs"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active malignancy defined as >1-cm disease on most recent CT scan in the past 6 months or recent history of cancer (i.e. within the past 5 years) with >50% chance of cancer recurrence in the next 5 years.",
            "criterions": [
                {
                    "exact_snippets": "Active malignancy defined as >1-cm disease on most recent CT scan in the past 6 months",
                    "criterion": "malignancy on CT scan",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "recent history of cancer (i.e. within the past 5 years) with >50% chance of cancer recurrence in the next 5 years",
                    "criterion": "history of cancer",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "recurrence risk",
                            "expected_value": {
                                "operator": ">",
                                "value": 50,
                                "unit": "percent"
                            }
                        },
                        {
                            "requirement_type": "recurrence time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active uncontrolled systemic fungal, bacterial, or viral infection (defined as ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment).",
            "criterions": [
                {
                    "exact_snippets": "Active uncontrolled systemic fungal, bacterial, or viral infection (defined as ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment)",
                    "criterion": "systemic fungal infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "systemic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infection_status",
                            "expected_value": "ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment"
                        }
                    ]
                },
                {
                    "exact_snippets": "Active uncontrolled systemic ... bacterial ... infection (defined as ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment)",
                    "criterion": "systemic bacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "systemic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infection_status",
                            "expected_value": "ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment"
                        }
                    ]
                },
                {
                    "exact_snippets": "Active uncontrolled systemic ... viral infection (defined as ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment)",
                    "criterion": "systemic viral infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "systemic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infection_status",
                            "expected_value": "ongoing signs/symptoms related to the infection without improvement despite appropriate antibiotics, antiviral therapy, and/or other treatment"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}